A Canadian scientist is questioning the effectiveness of privately funded efforts to stop the epidemic of breast cancer among North American women.
"Breast cancer has been transformed into a market-driven industry," said Queen's University kinesiology and health studies researcher Samantha King. "It has become more about making money for corporate sponsors than funding innovative ways to treat breast cancer."
King's research traces breast cancer's transformation from a stigmatized disease and individual tragedy to what she describes as "a market-driven industry that feeds off breast cancer survivors."
According to her research, only 64 percent of the money raised from one high-profile corporation's walk for breast cancer actually went to breast cancer organizations.
King also documents how the event and its logo have become products brought and sold by North American corporate sponsors and "the extent to which fundraising for breast cancer has become a highly valued commodity in itself."
The research appears in a book published by the University of Minnesota Press entitled "Pink Ribbons Inc."
Copyright 2006 by United Press International
Related stories:
Want a reason to love your lower belly fat? It's rich in stem cells
Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body, reports a Brazilian-based study in August's
Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). This is the first study of its kind to examine whether fat tissues from different areas of the body vary in stem cell concentration.
No need for gene screens in breast cancer families
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal
BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
New breast cancer test under study
Whether a painless, portable device that uses electrical current rather than X-ray to look for breast cancer could be an alternative to traditional mammograms is under study at the Medical College of Georgia.
Over-the-counter anesthetic gel puts the squeeze on mammogram pain
The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of
Radiology.
Cancer researchers call for ethnicity to be taken into account
Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's
Lancet (18 July) by researchers from Imperial College London.
New approach to cancer: Find most tightly controlled genes
Scientists at a Duke University medical school in Singapore have found a new way to study cancer that could be very useful for developing targeted therapies against cancer and possibly many other diseases.
First worldwide analysis of cancer survival finds wide variation between countries
Cancer survival varies widely between countries according to a worldwide study published online today in
Lancet Oncology.* More than 100 investigators contributed to the study.
New approach sheds light on ways Circadian disruption affects human health
Growing evidence indicates that exposure to irregular patterns of light and darkness can cause the human circadian system to fall out of synchrony with the 24-hour solar day, negatively affecting human health — but scientists have been unable to effectively study the relationship between circadian disruptions and human maladies.